Cloverleaf Bio

New Haven, CT · Founded 2023 · Privately Held (backing)

Developer of a Ribonucleic Acid (RNA) therapeutics development platform designed to revolutionize cancer therapy and patient outcomes in oncology. Cloverleaf Bio is based in New Haven, CT and was founded in 2023. It has raised $1.1 million.

Last price · $/share
—
Implied valuation
—
Total raised
$1.1M
Last round
—

Who backs Cloverleaf Bio?

10 investors
InvestorType
Creative Destruction LabOther
Endless Frontier Labs—
Pillar VCVenture capital
2048 VenturesVenture capital
Mission BioCapitalVenture capital
BrightEdgeVenture capital
MassBioOther
Eli Lilly—
National Cancer Institute—
Reinforced Ventures—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Cloverleaf Bio investors

10 investors are on record for Cloverleaf Bio, including Creative Destruction Lab, Endless Frontier Labs, Pillar VC and 2048 Ventures.

Private Market View
More of Cloverleaf Bio with a free Private Market View account
  • ·Watch Cloverleaf Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 10 firms already write checks for companies like Cloverleaf Bio. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View